These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23742289)

  • 21. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
    Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
    Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.
    Liu X; Li T; Diao S; Cai X; Kong Y; Zhang L; Wang Z; Li R; Zhou Y; Fang Q
    Neurol Sci; 2019 Jun; 40(6):1157-1166. PubMed ID: 30830567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
    Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
    Jha R; Battey TW; Pham L; Lorenzano S; Furie KL; Sheth KN; Kimberly WT
    Stroke; 2014 Apr; 45(4):1040-5. PubMed ID: 24619394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
    Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
    Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
    Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
    JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early neurological stability predicts adverse outcome after acute ischemic stroke.
    Irvine HJ; Battey TW; Ostwaldt AC; Campbell BC; Davis SM; Donnan GA; Sheth KN; Kimberly WT
    Int J Stroke; 2016 Oct; 11(8):882-889. PubMed ID: 27334760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
    Ramos-Fernandez M; Bellolio MF; Stead LG
    J Stroke Cerebrovasc Dis; 2011; 20(1):47-54. PubMed ID: 21044610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis.
    Pawluk H; Grześk G; Kołodziejska R; Kozakiewicz M; Woźniak A; Grzechowiak E; Szumny M; Sobolewski P; Bieniaszewski L; Kozera G
    Clin Interv Aging; 2020; 15():1295-1303. PubMed ID: 32821090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
    Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA.
    Sobrino T; Millán M; Castellanos M; Blanco M; Brea D; Dorado L; Rodríguez-González R; Rodríguez-Yáñez M; Serena J; Leira R; Dávalos A; Castillo J
    J Thromb Haemost; 2010 Jul; 8(7):1567-74. PubMed ID: 20456746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke.
    Wu W; Asakawa T; Yang Q; Zhao J; Lu L; Luo Y; Gong P; Han S; Li W; Namba H; Wang L
    Neurol Res; 2017 Oct; 39(10):862-868. PubMed ID: 28738762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?
    Berger C; Fiorelli M; Steiner T; Schäbitz WR; Bozzao L; Bluhmki E; Hacke W; von Kummer R
    Stroke; 2001 Jun; 32(6):1330-5. PubMed ID: 11387495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
    Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.